Unknown PHASE2/PHASE3 INTERVENTIONAL 2-arm NCT00835939

Treatment for Achilles Tendinopathy

Sponsor: Sport Science Association of Alberta (SSAA)

Conditions Achilles Tendinopathy Achilles Tendon Enthesopathy Insertional Achilles Tendinopathy Mid-Portion Achilles Tendinopathy Non-Insertional Achilles Tendinopathy

Interventions 25% Dextrose and 1% Lidocaine Lidocaine sclerotherapy

Updated 4 times since 2017 Last updated: Feb 3, 2009 Started: Sep 30, 2007 Primary completion: Jan 31, 2010

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE2/PHASE3 clinical study on Achilles Tendinopathy and Achilles Tendon Enthesopathy, this trial is ongoing. The trial is conducted by Sport Science Association of Alberta (SSAA) and has accumulated 4 data snapshots since 2007. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

4 versions recorded

Sep 2024 — Present [monthly]

Unknown PHASE2/PHASE3
Jul 2024 — Sep 2024 [monthly]

Unknown PHASE2/PHASE3

Status: Unknown Status → Unknown · Phase: PHASE2_PHASE3 → PHASE2/PHASE3
Jan 2021 — Jul 2024 [monthly]

Unknown Status PHASE2_PHASE3
Jan 2017 — Jan 2021 [monthly]

Unknown Status PHASE2_PHASE3

First recorded

Sep 2007

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Sport Science Association of Alberta (SSAA)
University of Calgary

Data source: University of Calgary

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Calgary, Canada